Empirically observed distributions of pharmacokinetic and pharmacodynamic variability in humans-implications for the derivation of single-point component uncertainty factors providing equivalent protection as existing reference doses

Toxicokinetics and Risk Assessment

Volumn , Issue , 2016, Pages 69-93

  Hattis, Dale ^a   Lynch, Meghan Keaney ^b  

^a CLARK UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85122908106     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (12)

1. Meek ME, Renwick AG, Chanian E, et al. Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment. Toxicology 2002; 27:115-120.
2. Hattis D, Baird S, Goble R. A straw man proposal for a quantitative definition of the RfD. Drug Chem Toxicol 2002; 25:403-436.
3. Hattis D, Banati P, Goble R. Distributions of individual susceptibility among humans for toxic effects. How much protection does the traditional tenfold factor provide for what fraction of which kinds of chemicals and effects? Ann NY Acad Sci 1999; 895:286-316.
4. http://www2.clarku.edu/faculty/dhattis.
5. Hattis D, Banati P, Coble R, et al. Human interindividual variability in parameters related to health risks. Risk Anal 1999; 19:711-720.
6. Baird SJS, Cohen JT, Graham JD, et al. Noncancer risk assessment: a probabilistic alternative to current practice. Human Ecol Risk Assess 1996; 2:79-102.
7. Weil CS, McCollister DD. Relationship between short and long-term feeding studies in designing an effective toxicity test. Agric Food Chem 1963; 11:486-491.
8. Nessel CS, Lewis SC, Stauber KL, et al. Subchronic to chronic exposure extrapolation: toxicologic evidence for a reduced uncertainty factor. Human Ecol Risk Assess 1995; 1:516-524.
9. Evans JS, Baird SJS. Accounting for missing data in noncancer risk assessment. Human Ecol Risk Assess 1998; 4:291-317. [b12].
10. Lehman AJ, Fitzhugh OG. 100-fold margin of safety. Assoc Food Drug Off 1954; 18:33-35.
11. Hattis D, Ginsberg G, Sonawane B, et al. Differences in pharmacokinetics between children and adults. II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal 2003; 23:117-142.
12. Haas CN. Dose-response analysis using spreadsheets. Risk Anal 1994; 14:1097-1100.